Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro

Pancreas

Volumn 22, Issue 1, 2001, Pages 58-64

  Guenifi, Amel ^a,c   Ahrén, Bo ^a,b   Abdel Halim, Samy M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arginine; Cholecystokinin; Glucagon like peptide 1 (7 36)amide; Islet hormone secretion

Indexed keywords

ARGININE; CHOLECYSTOKININ; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCAGON RELEASE; HORMONE RELEASE; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; NUTRIENT; PANCREAS ISLET; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SOMATOSTATIN RELEASE;

ANIMALS; ARGININE; CHOLECYSTOKININ; DRUG COMBINATIONS; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; INSULIN; MALE; MICE; PANCREAS; PEPTIDE FRAGMENTS; PERFUSION; RATS; SOMATOSTATIN;

EID: 0035158210     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200101000-00010     Document Type: Article

References (29)

1. The incretin concept today
2. Gut hormones and diabetes mellitus
3. Cholecystokinin and the regulation of insulin secretion
4. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
5. Glucagon-like peptide 1 (GLP-1) - A gut hormone of potential interest in the treatment of diabetes
6. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1
7. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus
8. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach
9. Effects of cholecystokinin, gastric inhibitory polypeptide and secretin on insulin and glucagon secretion in rats
10. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig
11. Antidiabetogenic action of cholecystokinin-8 in type-2 diabetes
12. The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinaemia in NIDDM patients
13. Near-normalization of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM
14. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans
15. L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide
16. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus
17. Étude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB419 ou glibenclamide
18. Coated charcoal immunoassay of insulin
19. Radioimmunoassay technique
20. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon and somatostatin from isolated perfused rat pancreas
21. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion
22. (7-36)amide: Influence on basal and stimulated insulin and glucagon secretion in the mouse
23. Effects of selective and nonselective β-adrenergic agents on insulin secretion in vivo
24. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas
25. Interaction of glucagon-like peptide-1 (7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas
26. Physiology and pathophysiology of insulin secretion
27. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8
28. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice
29. Glucagonlike peptide-1 (7-36) amide suppresses glucagon secretion and decreases cyclic AMP concentration in cultured IN-R1-G9 cells